Top Markets
Coin of the day
Stella Diagnostics Inc. Stella Diagnostics Inc.

Stella Diagnostics Inc.

SLDX
Rang in Aktien #38827
Stella Diagnostics Inc. is a molecular diagnostics firm primarily focused on... Stella Diagnostics Inc. is a molecular diagnostics firm primarily focused on advancing patient care strategies for individuals afflicted with severe esophageal disorders. The company's specialized clinical tests furnish physicians with crucial information regarding the molecular makeup of a patient's tissue, enabling them to ascertain if the disease is static, deteriorating, or undergoing malignant transformation. Additionally, Stella Diagnostics is engaged in the development of innovative diagnostic tools intended to provide healthcare professionals with enhanced molecular insights compared to conventional screening methods. The organization rebranded from its previous identity, JMP Properties, Inc., to Stella Diagnostics, Inc. in April 2021 and is based in Salt Lake City, Utah.
Aktienkurs
$0.00806
Zuletzt synchronisiert: 2026-08-13
Marktkapitalisierung
$786.26K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
-73.13%
Land
US
Handel Stella Diagnostics Inc. (SLDX)

Kategorie

Dividendenrendite-Verlauf für Stella Diagnostics Inc. (SLDX)
Dividendenrendite (TTM) von Stella Diagnostics Inc. (Aktienkürzel: SLDX) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Stella Diagnostics Inc. (SLDX) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber